Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Publication of ECSP10010028ApublicationCriticalpatent/ECSP10010028A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a un método para el tratamiento de síntomas vasomotores, que comprende la administración de una cantidad terapéuticamente eficaz de flibanserina.The invention relates to a method for the treatment of vasomotor symptoms, which comprises the administration of a therapeutically effective amount of flibanserin.
Compounds derived from 1-cyano-3-pyrrolidinyl-n-substituted-sulfonamides, cathepsin c inhibitors; pharmaceutical composition comprising said compound; and use of the compound for the treatment of a chronic obstructive pulmonary disease.
2-Oxo-1-pyrrolidinyl-imidazothiadiazole derived compounds; pharmaceutical composition comprising them; useful for the treatment of epilepsy, neurological disorders, among others.